Cas:12036-37-2 Zinc oxostannanediolate manufacturer & supplier

We serve Chemical Name:Zinc oxostannanediolate CAS:12036-37-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Zinc oxostannanediolate

Chemical Name:Zinc oxostannanediolate
CAS.NO:12036-37-2
Synonyms:Stannanediolate, 1-oxo-, zinc salt (1:1);Zinc oxostannanediolate
Molecular Formula:O3SnZn
Molecular Weight:232.117
HS Code:

Physical and Chemical Properties:
Melting point:>570ºC
Boiling point:N/A
Density:3,9 g/cm3
Index of Refraction:
PSA:63.19000
Exact Mass:231.816086
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Stannanediolate, 1-oxo-, zinc salt (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Zinc oxostannanediolate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Zinc oxostannanediolate Use and application,Zinc oxostannanediolate technical grade,usp/ep/jp grade.


Related News: More than 50% of patients with SLE develop permanent organ damage, caused by the disease or existing treatments, which exacerbates symptoms and increases the risk of mortality. 2H-1,2,4-Benzothiadiazine-3(4H)-thione, 2-propyl-, 1,1-dioxide manufacturers The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. 4,4′-(1-phenylethene-1,2-diyl)dipyridine suppliers Regulators approved the shot in May but paused the deployment amid lingering concerns about blood clots. Japan has so far relied vaccines made by Pfizer Inc (PFE.N) and Moderna Inc (MRNA.O) in its inoculation push. 3,5-diphenyl-4-(3-trifluoromethyl-phenyl)-4H-[1,2,4]triazole vendor & factory.